// App-Quantinova.ai

e19084 : Circulating tumor cells and evaluation of targeted therapy effect in EGFR mutation/ALK translocation metastatic non-small cell lung cancer.

Researchers

Presenter

  • ChunXia Su

Principal Investigators

  • Xuefei Li

  • Jing Zhao

  • Xiaoxia Chen

  • Chao Zhao

  • Caicun Zhou

  • Shengxiang Ren

  • Guanghui Gao

  • Wei Li

Medical Centers

  • Tongji University Medical School Cancer Institute, Shanghai, China

  • Department of Medical Oncology, Tongji University Affiliated Shanghai Pulmonary Hospital, Shanghai, ChinaDepartment of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Tongji University Medical School Cancer Institute, Shanghai, ChinaShanghai Pulmonary Hospital, Tongji University, Tongji University Medical School Cancer Institute, Shanghai, China

  • Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Tongji University Medical School Cancer Institute, Shanghai, China

  • Tongji University School of Medicine, Shanghai, China

  • Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China

  • Department of Lung Cancer and Immunology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Anaplastic lymphoma Kinase

  • Circulating tumor cells

  • Epidermal growth factor receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved